An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Summary

This is a multicenter, open-label extension of the clinical study NLS-1021, evaluating long-term safety, tolerability, pharmacokinetics (PK), and therapeutic response to treatment with NLS-2 in adult subjects with narcolepsy.

Timeline

Start

2021-10-26

Primary completion

2023-01-19

Completion

2023-01-19

Drugs

Indications